This principle is illustrated by several recent studies that are described below, which have implicated PLXNB3 and NARF as novel mediators of breast cancer stem cell specification and elucidated a novel mechanism by which telomerase activity is reactivated in breast cancer stem cells. Here, PLXNB3 is linked to breast carcinoma.